GNH USA

Europe — EMA

Granored (Granisetron)

Granored is an oral prescription drug containing granisetron, a 5‑HT3 antagonist used to prevent chemotherapy‑ and postoperative‑induced nausea and vomiting.

Granisetron

Request sourcing

1
Pack/s

What is Granisetron?

Granored is a prescription oral medication that contains the selective 5‑HT3 receptor antagonist granisetron. It is marketed in the European Union and is supplied without a specified strength or dosage form in the public data. Granisetron works by blocking serotonin receptors in the central nervous system, which helps to reduce the stimulation of the vomiting centre. Granored is used under medical supervision for nausea and vomiting control.

What is Granisetron used for?

Granored is indicated for the prevention and treatment of nausea and vomiting associated with specific medical procedures.

- Chemotherapy‑induced nausea and vomiting (CINV) - Post‑operative nausea and vomiting (PONV) - Nausea related to radiation therapy - Antiemetic prophylaxis in patients receiving highly emetogenic chemotherapy

What are the side effects of Granisetron?

The safety profile of granisetron includes both frequent, mild reactions and rare, more serious events.

Common: - Headache - Constipation - Diarrhoea - Fatigue - Dizziness

Serious: - Allergic reaction (rash, itching, swelling) - Cardiac arrhythmia - Severe hypotension

What precautions apply to Granisetron?

Before prescribing Granored, clinicians should evaluate patient history and consider several precautionary factors.

- Assess for known hypersensitivity to granisetron or other 5‑HT3 antagonists - Use cautiously in patients with prolonged QT interval or cardiac conduction disorders - Monitor electrolytes and cardiac status in patients receiving concurrent cardiotoxic chemotherapy - Adjust dose or avoid in severe hepatic impairment - Consider pregnancy and lactation status; safety data are limited

What does Granisetron interact with?

Granisetron may interact with other medicines, and certain combinations should be avoided or used with careful monitoring.

Avoid: - Concurrent use with other 5‑HT3 antagonists (e.g., ondansetron) due to additive effects - Co‑administration with drugs that significantly prolong the QT interval

Use with caution: - Antifungal agents such as ketoconazole that inhibit CYP3A4 - Certain anti‑emetics like aprepitant that affect metabolism - Drugs that alter cardiac conduction (e.g., certain antiarrhythmics)

Frequently asked questions

What type of medication is Granored and what is its active ingredient?+
Granored is a prescription oral medication whose active ingredient is granisetron, a selective 5‑HT3 receptor antagonist.
For which conditions is Granored commonly prescribed in clinical practice?+
Granored is commonly prescribed to prevent or treat chemotherapy‑induced nausea and vomiting and postoperative nausea and vomiting.
How does granisetron, the ingredient in Granored, work to reduce nausea?+
Granisetron blocks serotonin 5‑HT3 receptors in the central nervous system, preventing activation of the vomiting centre and thereby reducing nausea.
Can Granored be used for radiation‑therapy‑related nausea?+
Yes, granisetron may be used to manage nausea associated with radiation therapy, although it is primarily indicated for chemotherapy and postoperative settings.
What are the most frequently reported side effects of Granored?+
Common side effects include headache, constipation, diarrhoea, fatigue, and dizziness.
What serious adverse reactions should patients be aware of when taking Granored?+
Serious reactions, although rare, can include allergic responses such as rash or swelling, cardiac arrhythmias, and severe hypotension.
Should patients with a history of heart rhythm problems avoid Granored?+
Patients with prolonged QT interval or other cardiac conduction disorders should use Granored cautiously and be monitored closely.
Are there any drug interactions that require patients to avoid combining Granored with other medicines?+
Granored should be avoided with other 5‑HT3 antagonists and with drugs that significantly prolong the QT interval.
Which medications should be used with caution together with Granored?+
Caution is advised when Granored is taken with CYP3A4 inhibitors such as ketoconazole, anti‑emetics like aprepitant, and antiarrhythmic agents that affect cardiac conduction.
Is Granored safe to use during pregnancy or while breastfeeding?+
Safety data for granisetron during pregnancy and lactation are limited; clinicians should evaluate the risk‑benefit ratio before prescribing.
What monitoring is recommended for patients on Granored who have liver impairment?+
Patients with severe hepatic impairment may require dose adjustment or avoidance, and liver function should be monitored during therapy.
How is Granored classified under the ATC coding system?+
Granisetron, the active ingredient in Granored, is classified under ATC code A04AA10.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Granisetron
Route
Oral Use
Manufacturer
Dr. Reddy's Laboratories Romania S.R.L.
Origin
EU

Related products

Emegar

Emegar

Granisetron

Stada Arzneimittel Ag
EU
Grandise

Grandise

Granisetron

Lanova Farmaceutici S.R.L.
EU
Granegis

Granegis

Granisetron

Egis Pharmaceuticals Plc
EU
Granegis

Granegis

Granisetron

Egis Pharmaceuticals Plc
EU